T. Windahl et al., UPTAKE AND DISTRIBUTION OF INTRAVENOUSLY OR INTRAVESICALLY ADMINISTERED PHOTOSENSITIZERS IN THE RAT, Cancer letters, 75(1), 1993, pp. 65-70
Photodynamic therapy using i.v. injected porphyrin photosensitizers ha
ve been used to treat selected cases of superficial bladder cancer. Si
nce cutaneous photosensitivity, lasting 6-8 weeks, is a well known und
esirable side effect of this therapy, we instilled the photosensitizer
s intravesically in rats and compared the uptake of photosensitizers i
n different tissues by this route of administration with the uptake af
ter intravenous injection. The intravesical mode of delivery enhanced
photosensitizer uptake in the bladder wall, while giving low concentra
tions in extravesical organs. Intravesical instillation of the photose
nsitizers may therefore increase their efficacy and reduce phototoxici
ty as compared with intravenous injection. Comparing the results obtai
ned by two assays, one based on porphyrin fluoroscence and the other b
ased on the application of radioactively labelled photosensitizers, it
was concluded that the i.v. administration route may result in tissue
uptake of significant amounts of aggregated non-fluorescent, supposed
ly inactive drug, while the intravesical administration led to less up
take of aggregates relative to active drug monomers.